Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Veralox Therapeutics

Request full access

Veralox Therapeutics is a small molecule drug discovery and development firm based in the Frederick Innovative Technology Center, Inc

Frederick, United StatesFounded 2018Biotech & Life Sciences

About Veralox Therapeutics

Veralox Therapeutics is a biotechnology company focused on developing innovative small molecule therapeutics that address the underlying causes of thrombosis and type 1 diabetes. By leveraging a deep understanding of the molecular mechanisms driving these diseases, Veralox aims to create new treatment paradigms that significantly improve patient outcomes. The company operates in the biopharmaceutical market, primarily serving patients with unmet medical needs. Veralox's business model involves the research, development, and commercialization of novel therapeutics, generating revenue through product sales, partnerships, and potential licensing agreements. The recent FDA Orphan Drug Designation for VLX 1005 and a successful Series A financing round underscore the company's growth and potential impact in the healthcare sector.

Source: Dealroom company data

At a glance

Status
Operational
Employees
9
Open positions
None listed
Dealroom signal
57.8/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Drug Development, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus
B2B
Investment activity
1 company, latest Jan 2025
Capital deployed
—
Preferred round
ACQUISITION

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Jun 2023 $24M $96M Hatteras Venture Partners · Sanofi Ventures · NYBC Ventures · Pappas Capital ↗
SERIES A✓Equity / VC Jun 2021 $17M $66M Virginia Tech Carilion (VTC) Innovation Fund · Genesys Capital · Point Field Partners · Hatteras Venture Partners —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Veralox Therapeutics website traffic

Latest recorded traffic for Veralox Therapeutics is 860 monthly website visits, down 38.6% over the last three months. Veralox Therapeutics's team declined 25% over the past year.

Latest monthly visits860 3-month web change-38.6% 1-year team growth-25%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Veralox Therapeutics in the Frederick ecosystem

Live from Dealroom

The Veralox Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

16 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • VTC Seed Fund
  • Sanofi Ventures
  • Virginia Tech Carilion (VTC) Innovation Fund
  • JDRF T1D Fund

Series A8 investors entered at this stage

  • Hatteras Venture Partners
  • Genesys Capital
  • Point Field Partners
  • TEDCO
  • Alexandria Venture Investments
  • Maryland Momentum Fund
  • NYBC Ventures
  • Pappas Capital

Other known investors4 additional known investors

  • Eastern Virginia Medical School
  • National Institutes of Health
  • Alumni Ventures
  • VTC Ventures
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Frederick HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Veralox Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Veralox Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.